Motion

Motion TitleReclassification of Ketamine

Motion TextThat this Assembly commends the campaign of Sandra Larmour, who has fought with great dignity to increase awareness, and seek reclassification, of ketamine following the tragic death of her daughter Jeni; is alarmed that the prevalence of ketamine had reached record levels in recent years; stresses that ketamine is an extremely dangerous substance and can lead to serious health problems, such as irreversible damage to the bladder and kidneys; further stresses that it is one of the most detected substances in incidents of spiking; recognises that behind every drug-related death is a bereaved family; welcomes the UK Government’s decision to commission advice on whether ketamine should become a Class A drug; and calls on the Minister of Justice to work with the Home Office to put in place arrangements to allow affected families and relevant stakeholders from Northern Ireland to inform that independent review and future decisions on the regulation and classification of ketamine.

Motion CategoryPrivate Members' Motion

Date Tabled to Business Office04/02/2025

Date Selected By Committee18/02/2025

Date of Plenary Debate11/03/2025